• Produktbild: Biomarker Analysis in Clinical Trials with R
  • Produktbild: Biomarker Analysis in Clinical Trials with R
- 19%

Biomarker Analysis in Clinical Trials with R

19% sparen

59,99 € UVP 74,30 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

13.12.2021

Abbildungen

38 SW-Abb.

Verlag

Taylor & Francis

Seitenzahl

230

Maße (L/B/H)

23,4/15,6/1,3 cm

Gewicht

357 g

Sprache

Englisch

ISBN

978-1-03-224245-3

Beschreibung

Rezension

I can imagine applied statisticians having a hardcover version on their desks near their computer, in a somewhat overused condition, referring to this every now and then for the implementation of the described methods in practice. Goal achieved in such a case.

- Christos T. Nakas, International Society for Clinical Biostatistics, 71, 2021

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

13.12.2021

Abbildungen

38 SW-Abb.

Verlag

Taylor & Francis

Seitenzahl

230

Maße (L/B/H)

23,4/15,6/1,3 cm

Gewicht

357 g

Sprache

Englisch

ISBN

978-1-03-224245-3

Herstelleradresse

Produktsicherheitsverantwortliche/r
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Biomarker Analysis in Clinical Trials with R
  • Produktbild: Biomarker Analysis in Clinical Trials with R
  • Section I Pharmacodynamic Biomarkers 1. Introduction 2. Toxicology Studies 3. Bioequivalence Studies 4. Cross-Sectional Profile of Pharmacodynamics Biomarkers 5. Timecourse Profile of Pharmacodynamics Biomarkers 6. Evaluating Multiple Biomarkers Section II Predictive Biomarkers 7. Introduction 8. Operational Characteristics of Proof-of-Concept Trials with Biomarker-Positive and -Negative Subgroups 9. A Framework for Testing Biomarker Subgroups in Confirmatory Trials 10. Cutoff Determination of Continuous Predictive Biomarker for a Biomarker-Treatment Interaction 11. Cutoff Determination of Continuous Predictive Biomarker Using Group Sequential Methodology 12. Adaptive Threshold Design 13. Adaptive Seamless Design (ASD) Section III Surrogate Endpoints 14. Introduction 15. Requirement # 1: Trial Level - Correlation Between Hazard Ratios in Progression-Free Survival and Overall Survival Across Trials 16. Requirement # 2: Individual Level - Assess the Correlation Between the Surrogate and True Endpoints After Adjusting for Treatment (R2 indiv) 17. Examining the Proportion of Treatment Effect in AIDS Clinical Trials 18. Concluding Remarks Section IV Combining Multiple Biomarkers 19. Introduction 20. Regression-Based Models 21. Tree-Based Models 22. Cluster Analysis 23. Graphical Models Section V Biomarker Statistical Analysis Plan